91ºÚÁÏÍø

In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your 91ºÚÁÏÍø email for more information.
...
ALERTE McGILL! En raison de la pluie verglaçante, tous les cours et activités en présentiel prévus pour le mercredi 11 mars sont annulés. Nous demandons au personnel de ne pas se présenter sur le campus demain, à moins que leur superviseur ne leur demande d’être sur place pour accomplir des fonctions ou activités nécessaires au fonctionnement du campus. Pour plus d’informations, veuillez consulter vos courriels de 91ºÚÁÏÍø.
News

Rebuilding Life: Bioprinting and the Next Frontier in Medicine - Thu. Oct 9 @ 6pm

Published: 2 October 2025

A message from the 91ºÚÁÏÍø Institute for Advanced Materials (MIAM):

Attend our next "FUTURE OF MATERIALS" roundtable with Matt Kinsella and May Griffith on bioprinting, with demonstrations: Thu. October 9 at 6:00 pm, Arts W-120 (91ºÚÁÏÍø Campus). Please register at .

AT THE FOREFRONT OF TISSUE ENGINEERING, bioprinting is a technology where bio-inks and biomaterials, mixed with cells, are 3D printed, often to construct living tissue models. Join MIAM in welcoming 91ºÚÁÏÍø Professor of Bioengineering Matt Kinsella and University of Montreal Professor of Ophthalmology May Griffith, as they both give a broad view of this emerging field and explain their own work at its cutting edge.

MATT KINSELLA creates materials-based therapies to treat disease tissues, including using tissue engineering and 3D printing of protein gels to create models (or avatars) of tumors from patient samples. These models are potential alternatives to using animal models in biomedical research, and may allow us to develop more precise and personalized treatments. His lab is also designing and building automated robotic bioprinters that work alongside clinicians in the operating room to aid in the repair or reconstruction of organs following surgeries.

MAY GRIFFITH works on biomimetic materials, and in particular biomaterials that mimic collagen, the major structural protein in the human body. Her team developed the world’s first cell-free biosynthetic corneal implants that promoted endogenous tissue and nerve regeneration in a human clinical trial, showing for the first time that the cornea can regenerate, even in elderly patients. Her lab also focuses on immunomodulatory materials to suppress inflammation, allowing stable integration of biomaterials and cornea regeneration in patients at high risk for rejecting conventional donor cornea transplantation. They continue to explore new biomaterials with immunomodulatory and drug delivery capacity for clinical application.

The event will be moderated by MIAM Co-Director and 91ºÚÁÏÍø Professor of Materials Engineering MARTA CERRUTI.

Back to top